Profile

	CDNA	DHR-PB	TMO	DHR	A	IQV
Company Name	CareDx, Inc	Danaher Corporation	Thermo Fisher Scientific Inc.	Danaher Corporation	Agilent Technologies, Inc.	IQVIA Holdings Inc.
Sector	Healthcare	Healthcare	Healthcare	Healthcare	Healthcare	Healthcare
Industry	Medical - Diagnostics & Research	Medical - Diagnostics & Research	Medical - Diagnostics & Research	Medical - Diagnostics & Research	Medical - Diagnostics & Research	Medical - Diagnostics & Research
Market Cap	$977.71M	$916.76B	$193.40B	$146.49B	$35.11B	$33.79B
Employees	0.64K	79.00K	125.00K	61.00K	18.00K	88.00K
CEO	Mr. John Walter Hanna Jr.	Mr. Rainer M. Blair	Mr. Marc N. Casper	Mr. Rainer M. Blair	Mr. Padraig McDonnell	Mr. Ari Bousbib

Ratings

	CDNA	DHR-PB	TMO	DHR	A	IQV
Quant Rating Score	3	5	3	3	3	3
Quant Rating	Neutral	Strong Buy	Neutral	Neutral	Neutral	Neutral

Trading

	CDNA	DHR-PB	TMO	DHR	A	IQV
Last Close	$17.64	$1261.26	$508.9	$204.09	$117.33	$181.43
High 52	$33.99	$1261.26	$624.21	$280.76	$154.64	$254.26
Low 52	$7.56	$1261.26	$508.9	$201.62	$117.33	$181.43
Price vs. 52 Week High	-48.1 %	0 %	-18.47 %	-27.31 %	-24.13 %	-28.64 %
Price vs. 52 Week Low	133.33 %	0 %	0 %	1.23 %	0 %	0 %

Total Return

	CDNA	TMO	DHR	A	IQV
1 Month Return	-28 %	-4.32 %	-1.07 %	-12.88 %	-6.21 %
3 Month Return	-22.83 %	-3.41 %	-13.11 %	-15.59 %	-8.86 %
6 Month Return	-38.9 %	-16.73 %	-25.58 %	-14.55 %	-23.99 %
9 Month Return	24.31 %	-11.04 %	-19.92 %	-9.64 %	-14.72 %
YTD Return	-17.61 %	-2.18 %	-11.09 %	-12.66 %	-7.67 %
1 Year Return	76.93 %	-13 %	-19.4 %	-19.2 %	-28.64 %
3 Year Return	0 %	0 %	0 %	0 %	0 %
5 Year Return	0 %	0 %	0 %	0 %	0 %

Dividends

	CDNA	DHR-PB	TMO	DHR	A	IQV
Dividend Yield Percentage (TTM)	-	0.53 %	0.3 %	0.53 %	0.78 %	-
Dividend Paid and Capex Coverage Ration (TTM)	25 %	3.1 %	4.37 %	3.1 %	3.01 %	4.51 %
Dividend Per Share (TTM)	-	1.08 %	1.56 %	1.08 %	0.96 %	-
Payout Ratio (TTM)	-	19.7 %	9.2 %	19.7 %	21.92 %	-

Growth

	CDNA	DHR-PB	TMO	DHR
Asset Growth	5.19 %	-1.42 %	-8.22 %	10.06 %
Gross Profit Growth	87.18 %	5.81 %	1.23 %	2.02 %
Revenue Growth	19.07 %	0.05 %	-0.06 %	-4.73 %
Revenue 3 Year	11.48 %	12.79 %	-21.41 %	7.64 %
Revenue 5 Year	109.81 %	75.79 %	29.31 %	36.07 %
Revenue 10 Year	34.71 %	164.64 %	14.22 %	6.72 %
EBIT Growth	120.05 %	6.97 %	-6.52 %	10.22 %
Net Income Growth	127.62 %	5.67 %	-18.16 %	3.95 %
Net Income 3 Yeari Growth Per Share	269.65 %	-15.42 %	-41.24 %	11.3 %
Net Income 5 Yeari Growth Per Share	291.06 %	79.48 %	25.73 %	29.88 %
Net Income 10 Yeari Growth Per Share	641.51 %	248.59 %	42.96 %	196.82 %
Operating Income Growth	120.05 %	6.97 %	-6.52 %	10.22 %
Operating Cash Flow Growth (CFG)	306.92 %	3.1 %	-6.64 %	-1.19 %
Operating 3 Year CFG	295.21 %	-6.33 %	-22.42 %	23.19 %
Operating 5 Year CFG	1197.51 %	82.49 %	64.18 %	85.07 %
Operating 10 Year CFG	225.17 %	244.88 %	69.53 %	181.06 %
EPS Growth	128.25 %	6.76 %	-17.86 %	4.98 %
EPS Diluted Growth	126.27 %	7.06 %	-17.08 %	5.73 %
Book Value Per Share	47.53 %	7.15 %	-7.44 %	1.96 %
Share Holder 3 Year Equity Growth Per Share	-19.59 %	25.29 %	6.35 %	14.35 %
Share Holder 5 Year Equity Growth Per Share	205.32 %	74.85 %	58.77 %	34.05 %
Share Holder 10 Year Equity Growth Per Share	0.99 %	151.37 %	101.9 %	27.33 %
Dividend Per Share Growth	-	12.64 %	-6.53 %	4.47 %
Dividend 3 Year Growth Per Share	-	52.23 %	0.35 %	21.3 %
Dividend 5 Year Growth Per Share	-	105.55 %	41.45 %	43.54 %
Dividend 10 Year Growth Per Share	-	158.83 %	221.34 %	78.17 %
Debt Growth	-34.94 %	-10.43 %	-18.07 %	23.95 %
Free Cash Flow Growth	237.72 %	4.91 %	-8.39 %	-6.85 %
Updated On	31 Dec 2024	31 Dec 2024	31 Dec 2024	31 Oct 2024

Profitability

	CDNA	DHR-PB	TMO	DHR	A	IQV
Gross Profit Margin TTM	66.78 %	59.5 %	41.49 %	59.5 %	57.75 %	31.44 %
Return on Assets TTM	10.7 %	5.03 %	6.51 %	5.03 %	10.57 %	5.1 %
Return on Equity TTM	17.93 %	7.64 %	13.24 %	7.64 %	20.95 %	21.05 %
Return on Capital Employed TTM	10.17 %	6.87 %	8.73 %	6.87 %	14.73 %	11.27 %
Net Income Per EBT TTM	84.02 %	83.92 %	90.04 %	83.92 %	84.78 %	82.26 %
EBT Per Ebit TTM	153.18 %	95.54 %	95.98 %	95.54 %	100.34 %	74.24 %
EBIT Per Revenue TTM	12.23 %	20.37 %	17.1 %	20.37 %	22.65 %	14.59 %
Cash Flow To Debt Ratio TTM	170.9 %	41.79 %	27.71 %	41.79 %	50.46 %	206.07 %
Receivables Turnover TTM	5.17	6.75	5.23	6.75	4.92	4.06
Payables Turnover TTM	14.43	5.52	-	5.52	5.05	14.35
Inventory Turnover TTM	5.69	4.15	5.04	4.15	2.77	-
Fixed Asset Turnover TTM	576.56 %	478.46 %	460.77 %	478.46 %	359.75 %	1993.27 %
Asset Turnover TTM	67.97 %	30.79 %	44.06 %	30.79 %	54.83 %	57.28 %
Operating Cash Flow Per Share TTM	0.7	9.25	22.69	9.18	5.95	15.18
Free Cash Flow Per Share TTM	0.67	7.33	19.02	7.27	4.94	11.82
Cash Per Share TTM	480.17 %	287.53 %	1458.12 %	285.1 %	514.74 %	1030.18 %
Operating Cash Flow Sales Ratio TTM	11.4 %	28.01 %	20.21 %	28.01 %	25.98 %	17.63 %
Free Cash Flow Operating Cash Flow Ratio TTM	96 %	79.19 %	83.85 %	79.19 %	83.03 %	77.84 %
Cash Flow Coverage Ratios TTM	170.9 %	41.79 %	27.71 %	41.79 %	50.46 %	206.07 %
Price To Free Cash Flows Ratio TTM	26.77	27.54	26.61	27.66	24.92	15.98
Price To Operating Cash Flows Ratio TTM	25.17	22.05	22.6	22.34	20.67	12.62
Price Cash Flow Ratio TTM	25.17	22.05	22.6	22.34	20.67	12.62

Income Statement (TTM)

	CDNA	DHR-PB	TMO	DHR	A	IQV
Revenue	$0.33B	$23.88B	$42.88B	$23.88B	$6.51B	$15.41B
Gross Profit	$0.33B	$14.21B	$18.11B	$14.21B	$3.54B	$5.38B
Gross Profit Ratio	100%	59.5%	42.23%	59.5%	54.3%	34.89%
EBITDA	$-0.03B	$4.86B	$11.54B	$4.86B	$1.49B	$3.45B
Net Income	$0.05B	$3.9B	$6.34B	$3.9B	$1.29B	$1.37B
EPS Diluted	0.93	5.29	16.54	5.29	4.43	7.49

Balance Sheet (MRQ)

	CDNA	DHR-PB	TMO	DHR	A	IQV
Long Term Debt	$0.02B	$15.5B	$29.06B	$15.5B	$3.35B	$0.35B
Total Liabilities	$0.11B	$27.99B	$47.65B	$27.99B	$5.95B	$20.83B
Total Equity	$0.38B	$49.55B	$49.67B	$49.55B	$5.9B	$6.07B
Total Investments	$0.15B	$0B	$1.56B	$0B	$0.18B	$0.11B
Total Debt	$0.02B	$16.01B	$31.28B	$16.01B	$3.39B	$1.32B
Total Assets	$0.49B	$77.54B	$97.32B	$77.54B	$11.85B	$26.9B

Cash Flow Statement (TTM)

	CDNA	DHR-PB	TMO	DHR	A	IQV
Net Income	$0.05B	$3.9B	$6.34B	$3.9B	$1.29B	$1.37B
Inventory	$-0B	$0.15B	$0B	$0.15B	$0.03B	$0B
Dividends Paid	$0B	$-0.77B	$-0.58B	$-0.77B	$-0.27B	$0B
Operating Cash Flow	$0.04B	$6.69B	$8.67B	$6.69B	$1.75B	$2.72B
Capital Expenditure	$0B	$-1.39B	$-1.4B	$-1.39B	$-0.38B	$0B

Related Stocks

Ticker	Name	Price
A	Agilent Technologies, Inc.	121.17
ACRS	Aclaris Therapeutics, Inc.	1.555
ADVB	Advanced Biomed Inc. Common Stock	3.74
AKU	Akumin Inc.	0.2887
APDN	Applied DNA Sciences, Inc.	2.225
AWH	Aspira Women's Health Inc.	0.1399
BDSX	Biodesix, Inc.	0.7279
BIAF	bioAffinity Technologies, Inc.	0.367
BIAFW	bioAffinity Technologies, Inc.	0.3148
BIOC	Biocept, Inc.	0.4349
BNGO	Bionano Genomics, Inc.	3.475
BNR	Burning Rock Biotech Limited	5.96
CEMI	Chembio Diagnostics, Inc.	0.455
CHEK	Check-Cap Ltd.	0.7709
CNTG	Centogene N.V.	0.325
CO	Global Cord Blood Corporation	2.9876
CRL	Charles River Laboratories International, Inc.	171.11
CSTL	Castle Biosciences, Inc.	19.29
DGX	Quest Diagnostics Incorporated	170.17
DHR	Danaher Corporation	210.75

ETFs With Exposure to CDNA

Show entries

Search:

Ticker	ETF Name	Weight Percentage	Price
IWM	iShares Russell 2000 ETF	0.0399	202.88
VTI	Vanguard Total Stock Market Index Fund	0	276.95
XBI	SPDR S&P Biotech ETF	0.418886	87.1
IBB	iShares Biotechnology ETF	0.09499	134.17
SCHB	Schwab U.S. Broad Market ETF	0.00271643	21.685
ITOT	iShares Core S&P Total U.S. Stock Market ETF	0.00205	122.92
VB	Vanguard Small Cap Index Fund	0.01	223.56
SCHA	Schwab U.S. Small-Cap ETF	0.0409459	23.745
IWN	iShares Russell 2000 Value ETF	0.0635	152.74
IWV	iShares Russell 3000 ETF	0.00169	319.83

Showing 1 to 10 of 126 entries

Previous1 2 3 4 5…13Next

Unlock

Sign Up For Newsletters

Fidelitey

Fidelitey

Fidelitey

Fidelitey

Fidelitey

Company Details

Ratings

Quant Factor Grades

Trading

Dividend Grades

Dividend

Earnings

Valuation

Growth

Performance

Momentum

Profitability

Risk

Ownership

Debt